These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14988528)

  • 21. Infectious diseases. One year after outbreak, SARS virus yields some secrets.
    Enserink M
    Science; 2004 May; 304(5674):1097. PubMed ID: 15155925
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS treatment. Interferon shows promise in monkeys.
    Enserink M
    Science; 2004 Feb; 303(5662):1273-5. PubMed ID: 14988528
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe acute respiratory syndrome treatment: present status and future strategy.
    Lau AC; So LK
    Curr Opin Investig Drugs; 2003 Aug; 4(8):918-20. PubMed ID: 14508874
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of antiviral therapy for severe acute respiratory syndrome.
    Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW
    Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and vaccines for severe acute respiratory syndrome.
    Groneberg DA; Poutanen SM; Low DE; Lode H; Welte T; Zabel P
    Lancet Infect Dis; 2005 Mar; 5(3):147-55. PubMed ID: 15766649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy.
    Momattin H; Mohammed K; Zumla A; Memish ZA; Al-Tawfiq JA
    Int J Infect Dis; 2013 Oct; 17(10):e792-8. PubMed ID: 23993766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent patents on treatment of severe acute respiratory syndrome (SARS).
    Zhai S; Liu W; Yan B
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(9-10):41-6. PubMed ID: 22586904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS coronavirus anti-infectives.
    Tong TR
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):297-308. PubMed ID: 18221155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of anti-SARS agents.
    Shigeta S; Yamase T
    Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.
    Brunetto MR; Oliveri F; Colombatto P; Coco B; Ciccorossi P; Bonino F
    J Hepatol; 2003; 39 Suppl 1():S164-7. PubMed ID: 14708697
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiretroviral drugs in severe acute respiratory syndrome].
    Yazdanpanah Y; Guéry B
    Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on SARS research and other possibly zoonotic coronaviruses.
    Anderson LJ; Tong S
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S21-5. PubMed ID: 20801001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of chronic Hepatitis C in 2008].
    Niederau C; Kaden T
    MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
    [No Abstract]   [Full Text] [Related]  

  • 37. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon therapy for chronic hepatitis B].
    Hige S; Sho T; Nakanishi M; Chuma M
    Nihon Rinsho; 2011 May; 69 Suppl 4():481-5. PubMed ID: 22096965
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(7-8):42-6. PubMed ID: 22359870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.
    Tsang K; Seto WH
    Curr Opin Investig Drugs; 2004 Feb; 5(2):179-85. PubMed ID: 15043392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.